Vimarsana
Biggest News Aggregation in the World

Kerendia Phase News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Kerendia Phase. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Kerendia Phase Today - Breaking & Trending Today

Study Design and Baseline Characteristics of Prespecified, Exploratory Pooled Analysis to Investigate Effect of Finerenone on Cardio-Kidney Outcomes in Patients with CKD and Type 2 Diabetes and/or Heart Failure Shared at Heart Failure 2024 Congress - Vimarsana News

Study Design and Baseline Characteristics of Prespecified, Exploratory Pooled Analysis to Investigate Effect of Finerenone on Cardio-Kidney Outcomes in Patients with CKD and Type 2 Diabetes and/or Heart Failure Shared at Heart Failure 2024 Congress

Published: May 18, 2024

Baseline characteristics from FINE-HEART analysis highlight complex interplay between cardiovascular, kidney, and metabolic health, with over 92% of patients presenting two or more conditions

Source: dicardiology.com
Related Topics:
United StatesUs Medical Affairs CardiovascularAmerican Diabetes AssociationAmerican Association Of Clinical EndocrinologyEuropean Society Of CardiologyDrug AdministrationLate Breaking Science SessionHeart FailureEuropean SocietyRobert PerkinsVice PresidentKerendia PhaseAmerican AssociationClinical EndocrinologyKidney DiseaseImproving Global OutcomesPrescribing InformationChronic Kidney Disease
New Human Biomarker Findings Support Mechanism of Action of Kerendia® (finerenone) in Patients with - Vimarsana News

New Human Biomarker Findings Support Mechanism of Action of Kerendia® (finerenone) in Patients with

Published: November 3, 2023

FIGARO-BM, an exploratory human biomarker study, provides additional insight on finerenone's mechanism of action in blocking mineralocorticoid receptor (MR) overactivation1New data presented at the American Society of Nephrology’s (ASN) Kidney Week 2023WHIPPANY, N.J.--(BUSINESS WIRE)--At the American Society of Neph...

Source: pharmiweb.com
Related Topics:
United StatesSemin NephrolChristian RommelAmerican Society Of NephrologyClinical Trials ProgramCenters For DiseaseNational Diabetes StatisticsAmerican Kidney FundBayer Healthcare Pharmaceuticals IncNational Institutes Of HealthHead Of ResearchAmerican Diabetes AssociationNational Institute Of DiabetesAmerican Association Of Clinical EndocrinologyAmerican SocietyKidney WeekExecutive CommitteeDiabetic Kidney DiseaseKerendia PhaseAmerican DiabetesAmerican AssociationKidney DiseaseImproving GlobalPrescribing InformationChronic Kidney Disease Associated
New Human Biomarker Findings Support Mechanism of Action of Kerendia® (finerenone) in Patients with Chronic Kidney Disease Associated with Type 2 Diabetes - Vimarsana News

New Human Biomarker Findings Support Mechanism of Action of Kerendia® (finerenone) in Patients with Chronic Kidney Disease Associated with Type 2 Diabetes

Published: November 3, 2023

WHIPPANY, N.J.--(BUSINESS WIRE)--Nov 2, 2023--

Source: eagletribune.com
Related Topics:
United StatesSemin NephrolChristian RommelAmerican Kidney FundNational Diabetes StatisticsHead Of ResearchNational Institute Of DiabetesAmerican Diabetes AssociationBayer Healthcare Pharmaceuticals IncNational Institutes Of HealthClinical Trials ProgramAmerican Society Of NephrologyAmerican Association Of Clinical EndocrinologyCenters For DiseaseAmerican SocietyKidney WeekExecutive CommitteeKerendia PhaseAmerican AssociationClinical EndocrinologyKidney DiseaseImproving Global OutcomesPrescribing InformationforTrials ProgramChronic Kidney Disease Associated
Bayer's Kerendia® (finerenone) Included in Latest Focused Guideline Clinical Updates from European Society of Cardiology | Business - Vimarsana News

Bayer's Kerendia® (finerenone) Included in Latest Focused Guideline Clinical Updates from European Society of Cardiology | Business

Published: August 31, 2023

WHIPPANY, N.J.--(BUSINESS WIRE)--Aug 31, 2023--

Source: valdostadailytimes.com
Related Topics:
United StatesBayer KerendiaRobert PerkinsSemin NephrolNikolaus MarxTheresaa McdonaghNational Institutes Of HealthBayer Healthcare Pharmaceuticals IncAmerican Diabetes AssociationHeart Failure AssociationAmerican Association Of Clinical EndocrinologyCenters For DiseaseAmerican Kidney FundEuropean Society Of CardiologyClinical Trials ProgramNational Diabetes StatisticsNational Institute Of DiabetesEuropean SocietyChronic Heart FailureDrug AdministrationCardiovascular DiseaseVice PresidentKerendia PhaseAmerican AssociationClinical Endocrinology